Health & Wellness

Do Alternative Sources for CBD Exist? Meet Trema Micrantha Blume

mm
Add MyCannabis.com to your preferred sources on Google

As the demand for natural remedies continues to rise, cannabis and hemp have become household names, especially for cannabinoids like cannabidiol (CBD) and tetrahydrocannabinol (THC). These cannabinoids offer therapeutic benefits ranging from pain relief and anti-inflammatory properties to anxiety reduction. However, as the quest for plant-based therapeutics continues to evolve, researchers are exploring alternative plants that might offer similar health benefits without some of the legal, social, or psychoactive concerns surrounding cannabis. One such contender is Trema micrantha Blume, a tropical plant that has recently garnered attention for its potential cannabinoid properties. But is Trema micrantha Blume a viable alternative to cannabis and hemp? Let’s explore the science and why many are seeking out other therapeutic plants beyond hemp and cannabis.

The Rise of Cannabinoids: Why Look for Alternatives

When it comes to nourishing your body, you wouldn’t rely on just one type of fruit to meet all your needs. Each fruit offers unique vitamins, minerals, and antioxidants, and by eating a variety, you ensure a more balanced approach to health. The same principle applies to plant medicine—why rely on just one source when nature provides such a wide array of beneficial plants?

While cannabis and hemp products have gained widespread popularity in both recreational and medicinal contexts, not everyone is comfortable with or has access to cannabis. Legal restrictions, social stigma, and concerns about psychoactive effects prevent many from embracing it fully. This growing search for alternatives has led scientists and natural medicine experts to explore a variety of plants that offer similar benefits, with some of them even containing cannabinoids themselves. Recently, plants like Trema micrantha Blume have emerged as promising candidates to diversify the realm of cannabinoid medicine.

What is Trema micrantha Blume?

Trema micrantha Blume is a tropical tree native to warmer areas of the Western Hemisphere, with abundance in parts of Central and South America. Traditionally, the tree has been used in folk medicine, particularly in Brazil, where its leaves and bark are brewed into teas to treat various ailments, including fever, inflammation, pain, and digestive disorders. While this plant has been a staple in folk remedies for centuries, it’s now gaining fresh attention due to a groundbreaking discovery: the presence of CBD in Trema micrantha Blume.

A recent study led by molecular biologist Rodrigo Moura Neto from Brazil’s Federal University of Rio de Janeiro (UFRJ) revealed that the fruit and flower of Trema micrantha Blume contain cannabidiol (CBD), the same non-psychoactive compound found in hemp and cannabis. This finding is particularly exciting because Trema micrantha Blume does not contain THC—the psychoactive compound found in cannabis—making it a potential legal alternative for obtaining CBD in regions where it remains restricted.

Neto’s discovery is significant as it offers a new, abundant, and cost-effective source of CBD, without the regulatory challenges often associated with cultivation and use. In countries like Brazil, where planting cannabis and hemp is still illegal, Trema micrantha Blume could provide a legal pathway for producing CBD, which is increasingly being used for medicinal purposes.

Many have taken notice of this groundbreaking discovery and Neto and his team have received substantial funding from the Brazilian government to scale up their research and explore the best methods for extracting CBD from Trema micrantha Blume. Over the next several years, this research could revolutionize the way CBD is sourced and open up new possibilities for patients seeking plant-based remedies without the psychoactive effects or legal hurdles of cannabis.

Trema micrantha Blume stands as a promising candidate in the broader search for cannabinoid alternatives, offering a legal, accessible, and potentially more affordable solution for those looking to harness the therapeutic power of CBD.

Other Plant-Based Alternatives to CBD and THC

Trema micrantha Blume isn’t the only plant being investigated for cannabinoid-like effects. An array of other plants have garnered attention for their potential therapeutic properties, ability to produce cannabinoids, as well as their ability to interact with the endocannabinoid system. These include:

Echinacea

Known for its immune-boosting effects, echinacea contains compounds that interact with the endocannabinoid system, though in different ways than cannabis. Certain alkylamides found in echinacea activate CB2 receptors, which are responsible for immune system regulation as well as aiding in pain relief, reducing inflammation, and much more.

Helichrysum

This Mediterranean plant has been found to contain CBG, a cannabinoid also found in hemp and cannabis. Helichrysum has traditionally been used for its mood-enhancing properties, as well as for its potential to treat inflammation and digestive issues. Scientifically, it has been found to have a wide range of benefits, including anti-inflammatory, antioxidant, and antimicrobial effects.

Liverwort (Radula marginata)

Native to New Zealand, the liverwort plant produces a compound called perrottetinene, which has a similar structure to THC. Early studies suggest that perrottetinene interacts with CB1 receptors in the brain, much like THC, though its psychoactive effects are reported to be milder.

Trema micrantha Blume and other alternative plants are opening up an exciting new frontier in the quest for cannabinoid-like compounds. While cannabis remains a powerful and highly effective option for many, it’s becoming increasingly clear that the world of plant medicine is far more expansive than once believed. As ongoing research uncovers new possibilities, we may soon see a diverse range of natural sources providing cannabinoids, offering more choices for those seeking holistic wellness and plant-based therapies. The emergence of these alternatives signals a bright future for plant-based medicine, where the potential benefits of a wider variety of healing plants are just beginning to be realized.

Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.